Apexium Financial LP Has $1.50 Million Holdings in UnitedHealth Group Incorporated $UNH

Apexium Financial LP cut its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 4.3% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 4,816 shares of the healthcare conglomerate’s stock after selling 219 shares during the quarter. Apexium Financial LP’s holdings in UnitedHealth Group were worth $1,502,000 as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in the business. Citizens National Bank Trust Department raised its position in shares of UnitedHealth Group by 1.0% during the first quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate’s stock worth $9,368,000 after purchasing an additional 170 shares during the period. Fort Washington Investment Advisors Inc. OH raised its position in shares of UnitedHealth Group by 0.3% during the first quarter. Fort Washington Investment Advisors Inc. OH now owns 530,103 shares of the healthcare conglomerate’s stock worth $277,641,000 after purchasing an additional 1,465 shares during the period. Caitlin John LLC raised its position in shares of UnitedHealth Group by 14.8% during the first quarter. Caitlin John LLC now owns 862 shares of the healthcare conglomerate’s stock worth $451,000 after purchasing an additional 111 shares during the period. Triumph Capital Management acquired a new position in shares of UnitedHealth Group during the second quarter worth approximately $1,324,000. Finally, Wealth Effects LLC grew its holdings in UnitedHealth Group by 14.4% during the second quarter. Wealth Effects LLC now owns 4,688 shares of the healthcare conglomerate’s stock worth $1,463,000 after buying an additional 591 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on UNH shares. Robert W. Baird reiterated an “underperform” rating and set a $198.00 price target (down previously from $312.00) on shares of UnitedHealth Group in a report on Thursday, July 31st. Sanford C. Bernstein upped their price target on UnitedHealth Group from $337.00 to $379.00 and gave the stock an “outperform” rating in a report on Friday, September 5th. Weiss Ratings reiterated a “sell (d+)” rating on shares of UnitedHealth Group in a report on Saturday, September 27th. Royal Bank Of Canada reduced their price objective on UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating for the company in a research note on Wednesday, July 30th. Finally, Truist Financial upped their price objective on UnitedHealth Group from $310.00 to $365.00 and gave the company a “buy” rating in a research note on Tuesday, September 9th. Sixteen research analysts have rated the stock with a Buy rating, six have given a Hold rating and four have assigned a Sell rating to the company’s stock. According to data from MarketBeat, UnitedHealth Group currently has a consensus rating of “Hold” and an average target price of $358.95.

UnitedHealth Group Stock Up 1.8%

UNH stock opened at $360.17 on Friday. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The company has a market capitalization of $326.20 billion, a price-to-earnings ratio of 15.61, a PEG ratio of 2.30 and a beta of 0.47. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $630.73. The stock has a fifty day moving average of $307.84 and a 200-day moving average of $355.58.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). The firm had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm’s revenue was up 12.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were paid a dividend of $2.21 per share. The ex-dividend date was Monday, September 15th. This represents a $8.84 annualized dividend and a dividend yield of 2.5%. UnitedHealth Group’s dividend payout ratio is presently 38.30%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.